Favorable outcomes of DDX41 -mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide.
Ing Soo TiongWilliam S StevensonMeaghan WallYan Zhuang YapJohn F SeymourMelita KenealyPiers A Blomberynull nullPublished in: EJHaem (2023)